首站-论文投稿智能助手
典型文献
Preclinical evaluation and pilot clinical study of[18F]AlF-labeled FAPI-tracer for PET imaging of cancer associated fibroblasts
文献摘要:
In recent years,fibroblast activation protein(FAP)has emerged as an attractive target for the diag-nosis and radiotherapy of cancers using FAP-specific radioligands.Herein,we aimed to design a novel 18F-labeled FAP tracer([18F]A1F-P-FAPI)for FAP imaging and evaluated its potential for clinical application.The[18F]A1F-P-FAPI novel tracer was prepared in an automated manner within 42 min with a non-decay cor-rected radiochemical yield of 32±6%(n=8).Among A549-FAP cells,[1 8F]A1F-P-FAPI demonstrated spe-cific uptake,rapid internalization,and low cellular efflux.Compared to the patent tracer[18F]FAPI-42,[18F]A1F-P-FAPI exhibited lower levels of cellular efflux in the A549-FAP cells and higher stability in vivo.Micro-PET imaging in the A549-FAP tumor model indicated higher specific tumor uptake of[18F]A1F-P-FAPI(7.0±1.0%ID/g)compared to patent tracers[18F]FAPI-42(3.2±0.6%ID/g)and[68Ga]Ga-FAPI-04(2.7±0.5%ID/g).Furthermore,in an initial diagnostic application in a patient with nasopharyngeal cancer,[18F]A1F-P-FAPI and[18F]FDG PET/CT showed comparable results for both primary tumors and lymph node metastases.These results suggest that[18F]A1F-P-FAPI can be conveniently prepared,with promising charac-teristics in the preclinical evaluation.The feasibility of FAP imaging was demonstrated using PET studies.
文献关键词:
作者姓名:
Kongzhen Hu;Junqi Li;Lijuan Wang;Yong Huang;Li Li;Shimin Ye;Yanjiang Han;Shun Huang;Hubing Wu;Jin Su;Ganghua Tang
作者机构:
Department of Nuclear Medicine,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China;Shenzhen International Institute for Biomedical Research,Shenzhen 518116,China;National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital&Shenzhen Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Shenzhen 518116,China;State Key Laboratory of Respiratory Disease,National Clinical Research Center for Respiratory Disease,Guangzhou Institute of Respiratory Health,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510182,China
引用格式:
[1]Kongzhen Hu;Junqi Li;Lijuan Wang;Yong Huang;Li Li;Shimin Ye;Yanjiang Han;Shun Huang;Hubing Wu;Jin Su;Ganghua Tang-.Preclinical evaluation and pilot clinical study of[18F]AlF-labeled FAPI-tracer for PET imaging of cancer associated fibroblasts)[J].药学学报(英文版),2022(02):867-875
A类:
radioligands,A1F
B类:
Preclinical,evaluation,pilot,study,18F,AlF,labeled,FAPI,PET,imaging,associated,fibroblasts,In,recent,years,activation,protein,has,emerged,attractive,target,nosis,radiotherapy,cancers,using,specific,Herein,aimed,design,novel,evaluated,its,potential,application,was,prepared,automated,manner,within,decay,cor,rected,radiochemical,yield,Among,A549,cells,demonstrated,uptake,rapid,internalization,cellular,efflux,Compared,patent,exhibited,lower,levels,higher,stability,vivo,Micro,model,indicated,ID,compared,tracers,68Ga,Furthermore,initial,diagnostic,patient,nasopharyngeal,FDG,showed,comparable,results,both,primary,tumors,lymph,node,metastases,These,suggest,that,conveniently,promising,charac,teristics,preclinical,feasibility,studies
AB值:
0.446901
相似文献
Overexpressed NEDD8 as a potential therapeutic target in esophageal squamous cell carcinoma
Jingrong Xian;Shiwen Wang;Yanyu Jiang;Lihui Li;Lili Cai;Ping Chen;Yue Liu;Xiaofei Zeng;Guoan Chen;Chen Ding;Robert M.Hoffman;Lijun Jia;Hu Zhao;Yanmei Zhang-Department of Laboratory Medicine,Huadong Hospital Affiliated to Fudan University,Shanghai 200040,China;Cancer Institute,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Research Center on Aging and Medicine,Fudan University,Shanghai 200040,China;Shanghai Key Laboratory of Clinical Geriatric Medicine,Shanghai 200040,China;Department of Basic Science of Oncology,College of Basic Medical Sciences,Zhengzhou University,Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;School of Medicine,Southern University of Science and Technology,Shenzhen 518055,China;State Key Laboratory of Genetic Engineering,Human Phenome Institute,Institutes of Biomedical Sciences,School of Life Sciences,Zhongshan Hospital,Fudan University,Shanghai 200032,China;State Key Laboratory of Cell Differentiation and Regulation,Henan International Joint Laboratory of Pulmonary Fibrosis,Henan Center for Outstanding Overseas Scientists of Pulmonary Fibrosis,College of Life Science,Institute of Biomedical Science,Henan Normal University,Xinxiang 453007,China;Department of Surgery,University of California,San Diego 92101,USA;Anticancer Inc.,San Diego 92101,USA
Glycolytic potential enhanced by blockade of pyruvate influx into mitochondria sensitizes prostate cancer to detection and radiotherapy
Huan Xu;Junyi Chen;Zhi Cao;Xi Chen;Caihong Huang;Jin Ji;Yalong Xu;Junfeng Jiang;Yue Wang;Guowang Xu;Lina Zhou;Jingyi He;Xuedong Wei;Jason Boyang Wu;Zhong Wang;Shancheng Ren;Fubo Wang-Department of Urology,Shanghai Changhai Hospital,Second Military Medical University,Shanghai 200433,China;Department of Urology,Shanghai Ninth People's Hospital,Shanghai 200011,China;Department of Urology,the Second Affiliated Hospital of Fujian Medical University,Quanzhou 362000,China;Department of Urology,No.971 Hospital of the People's Liberation Army Navy,Qingdao 266000,China;Center for Genomic and Personalized Medicine,Guangxi Key Laboratory for Genomic and Personalized Medicine,Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine,Guangxi Medical University,Nanning 530021,China;Research Center of Developmental Biology,Second Military Medical University,Shanghai 200433,China;Dalian Institute of Chemical Physics,Chinese Academy of Sciences,Dalian 116023,China;Department of Urology,the First Affiliated Hospital of Soochow University,Suzhou 215006,China;Department of Pharmaceutical Sciences,College of Pharmacy and Pharmaceutical Sciences,Washington State University,Spokane,WA 99202,USA
A novel peptide-based probe 99mTc-PEG6-RD-PDP2 for the molecular imaging of tumor PD-L2 expression
Qi Luo;Yunwei Zhang;Zihua Wang;Yining Sun;Linqing Shi;Yue Yu;Jiyun Shi;Zhiyuan Hu;Fan Wang-Guangzhou Laboratory,Guangzhou 510005,China;Medical Isotopes Research Center and Department of Radiation Medicine,State Key Laboratory of Natural and Biomimetic Drugs,School of Basic Medical Sciences,Peking University,Beijing 100191,China;Fujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases,School of Basic Medical Sciences,Fujian Medical University,Fuzhou 350122,China;Key Laboratory of Protein and Peptide Pharmaceuticals,CAS Center for Excellence in Biomacromolecules,Institute of Biophysics,Chinese Academy of Sciences,Beijing 100101,China;CAS Key Laboratory of Standardization and Measurement for Nanotechnology,CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety,CAS Center for Excellence in Nanoscience,National Center for Nanoscience and Technology of China,Beijing 100190,China
Synthesis and characterization of the two enantiomers of a chiral sigma-1 receptor radioligand:(S)-(+)-and(R)-(-)-[18F]FBFP
Tao Wang;Ying Zhang;Xiaojun Zhang;Leyuan Chen;Mingqiang Zheng;Jinming Zhang;Peter Brust;Winnie Deuther-Conrad;Yiyun Huang;Hongmei Jia-Key Laboratory of Radiopharmaceuticals(Beijing Normal University),Ministry of Education,College of Chemistry,Beijing Normal University,Beijing 100875,China;Nuclear Medicine Department,The First Medical Center of Chinese PLA General Hospital,Beijing 100853,China;Institute of Radiation Medicine,Peking Union Medical College&Chinese Academy of Medical Sciences,Tianjin 300192,China;Yale PET Center,Department of Radiology and Biomedical Imaging,Yale University School of Medicine,New Haven,CT 06520-8048,United States;Helmholtz-Zentrum Dresden-Rossendorf,Institute of Radiopharmaceutical Cancer Research,Department of Neuroradiopharmaceuticals,Leipzig 04318,Germany
Pharmacodynamic,pharmacokinetic,and phase 1a study of bisthianostat,a novel histone deacetylase inhibitor,for the treatment of relapsed or refractory multiple myeloma
Yu-bo Zhou;Yang-ming Zhang;Hong-hui Huang;Li-jing Shen;Xiao-feng Han;Xiao-bei Hu;Song-da Yu;An-hui Gao;Li Sheng;Ming-bo Su;Xiao-li Wei;Yue Zhang;Yi-fan Zhang;Zhi-wei Gao;Xiao-yan Chen;Fa-jun Nan;Jia Li;Jian Hou-National Center for New Drug Screening,State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;Yantai Key Laboratory of Nanomedicine&Advanced Preparations,Yantai Institute of Materia Medica,Yantai 264000,China;Department of Hematology,Renji Hospital,Shanghai Jiaotong University School of Medicine,Shanghai 200127,China;Shanghai Center for Drug Metabolism and Pharmacokinetics Research,Shanghai 201203,China
Pharmacological characterization of a novel metal-based proteasome inhibitor Na-AuPT for cancer treatment
Da-cai Xu;Li Yang;Pei-quan Zhang;Ding Yan;Qian Xue;Qing-tian Huang;Xiao-fen Li;Ya-li Hao;Dao-lin Tang;Q.Ping Dou;Xin Chen;Jin-bao Liu-Affliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;The Department of Physiology,School of Basic Medical Sciences,Guizhou Medical University,Guiyang 550003,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
A novel monoacylglycerol lipase-targeted 18F-labeled probe for positron emission tomography imaging of brown adipose tissue in the energy network
Ran Cheng;Masayuki Fujinaga;Jing Yang;Jian Rong;Ahmed Haider;Daisuke Ogasawara;Richard S.Van;Tuo Shao;Zhen Chen;Xiaofei Zhang;Erick R.Calderon Leon;Yiding Zhang;Wakana Mori;Katsushi Kumata;Tomoteru Yamasaki;Lin Xie;Shaofa Sun;Lu Wang;Chongzhao Ran;Yihan Shao;Benjamin Cravatt;Lee Josephson;Ming-Rong Zhang;Steven H.Liang-Division of Nuclear Medicine and Molecular Imaging,Department of Radiology,Massachusetts General Hospital and Harvard Medical School,Boston,MA 02114,USA;School of Medical Imaging,Tianjin Medical University,Tianjin 300203,China;Department of Radiopharmaceuticals Development,National Institute of Radiological Sciences,National Institutes for Quantum and Radiological Science and Technology,Chiba 263-8555,Japan;Athinoula A.Martinos Center for Biomedical Imaging,Massachusetts General Hospital and Harvard Medical School,Boston,MA 02125,USA;The Skaggs Institute for Chemical Biology and Department of Chemical Physiology,The Scripps Research Institute,La Jolla,CA 92037,USA;Department of Chemistry and Biochemistry,University of Oklahoma,Norman,OK 73019,USA;Hubei Collaborative Innovation Centre for Non-power Nuclear Technology,College of Nuclear Technology&Chemistry and Biology,Hubei University of Science and Technology,Xianning,Hubei Province 437100,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。